The Anti-Ischemic Effect of Metoprolol in Patients with Chronic Angina Pectoris Is Gender-Specific
Authors:
- Giuseppe CoccoGCGiuseppe Cocco
- David ChuDCDavid Chu
- 1 September 2006
- journal article
- Published by S. Karger AG in Cardiology
- Vol. 106 (3) , 147-153
Abstract
Several gender-specific differences in cardiovascular diseases are known and pharmacokinetics of β-blockers shows relevant sex-specific differences. The plasma levels of metoprolol, for example, are higher in women compared to men. However, randomized studies have shown that metoprolol has little or no greater reduction in the mortality of women following myocardial infarction. We tested the hypothesis that metoprolol might have significant gender-specific effects in patients with chronic angina pectoris. Body weight of women was slightly (–9%) less than that of men and the daily dose of metoprolol was similar in both groups. Thus, according to pharmacokinetics women should have obtained higher plasma levels of this drug and the ensuing pharmacologic effects of metoprolol should have been greater. Our results do not confirm this assumption. Metoprolol reduced the frequency of angina episodes and the consumption of nitroglycerin tablets to a similar extent in both sexes. However, the pretreatment hemodynamic profiles confirmed the existence of gender-specific differences: women had significantly higher heart rate and blood pressure both at rest and during exercise. Since both groups were comparable in age, comorbidities, and medications, the existing difference is likely to be due to gender-specificity. The hemodynamic differences persisted during therapy with metoprolol: resting heart rate, blood pressure and rate pressure product were reduced to a greater extent in men. During cycloergometry, there was a slight difference in the time of onset of ST depression and time of onset of angina, which were slightly higher in men, but probably because of the limited number of cases, the difference between men and women did not reach significance. On the other hand, with metoprolol the duration of exercise and, in parallel, the number of metabolic equivalents was significantly greater in males than in females. Thus in spite of a presumed greater plasma concentration of metoprolol in women, we found a significant difference in anti-ischemic effect in favor of men. We conclude that metoprolol might exert a significantly greater therapeutic effect on stress-induced angina pectoris in men than in women and this difference should be taken into account when prescribing this β-blocker.Keywords
This publication has 16 references indexed in Scilit:
- Female-specific aspects in the pharmacotherapy of chronic cardiovascular diseasesEuropean Heart Journal, 2005
- Coronary atherogenic risk factors in womenEuropean Heart Journal, 2002
- Effect of Carvedilol on the Morbidity of Patients With Severe Chronic Heart FailureCirculation, 2002
- Estrogenic hormone action in the heart: regulatory network and functionCardiovascular Research, 2002
- Sex-Based Differences in Early Mortality after Myocardial InfarctionNew England Journal of Medicine, 1999
- GENDER DIFFERENCES IN MORTALITY AFTER MYOCARDIAL INFARCTIONCardiology Clinics, 1998
- Effect of Hormone Replacement Therapy on QT IntervalJACC, 1998
- Gender differences in heart rate before and after autonomic blockade: Evidence against an intrinsic gender effectThe American Journal of Medicine, 1996
- Upregulation of Collagen Type I Gene Expression in the Ventricular Myocardium of Thyroidectomized Male and Female RatsJournal of Molecular and Cellular Cardiology, 1996
- Human vascular smooth muscle cells contain functional estrogen receptor.Circulation, 1994